These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 11967389)
1. Thrombocytopenia and outcome in invasive cardiology. Lewis B J Invasive Cardiol; 2002 Apr; 14 Suppl B():38B-47B. PubMed ID: 11967389 [No Abstract] [Full Text] [Related]
2. Co-existence of heparin-induced thrombocytopenia and thrombotic thrombocytopenic purpura in a postoperative cardiac surgery patient. Benke S; Moltzan C Am J Hematol; 2005 Dec; 80(4):288-91. PubMed ID: 16315265 [TBL] [Abstract][Full Text] [Related]
3. Thrombocytopenia in patients treated with heparin, combination antiplatelet therapy, and intra-aortic balloon pump counterpulsation. Bream-Rouwenhorst HR; Hobbs RA; Horwitz PA J Interv Cardiol; 2008 Aug; 21(4):350-6. PubMed ID: 18537872 [TBL] [Abstract][Full Text] [Related]
4. Heparin-induced thrombocytopenia and cardiopulmonary bypass: anticoagulation with unfractionated heparin and the GPIIb/IIIa inhibitor tirofiban and successful use of rFVIIa for post-protamine bleeding due to persistent platelet blockade. Durand M; Lecompte T; Hacquard M; Carteaux JP Eur J Cardiothorac Surg; 2008 Sep; 34(3):687-9. PubMed ID: 18579401 [TBL] [Abstract][Full Text] [Related]
5. Thrombocytopenia in patients with an acute coronary syndrome (from the Global Registry of Acute Coronary Events [GRACE]). Gore JM; Spencer FA; Gurfinkel EP; López-Sendón J; Steg PG; Granger CB; FitzGerald G; Agnelli G; Am J Cardiol; 2009 Jan; 103(2):175-80. PubMed ID: 19121432 [TBL] [Abstract][Full Text] [Related]
6. The combination of enoxaparin, glycoprotein IIb/IIIa inhibitors and an early invasive approach among acute coronary syndrome patients. Lee DS; Bhatt DL; Moliterno DJ; Peacock WF; Ellis SG; Topol EJ J Invasive Cardiol; 2004 Feb; 16(2):46-51. PubMed ID: 14760188 [TBL] [Abstract][Full Text] [Related]
7. Contemporary view of the acute coronary syndromes. Moustapha A; Anderson HV J Invasive Cardiol; 2003 Feb; 15(2):71-9. PubMed ID: 12556619 [No Abstract] [Full Text] [Related]
8. Bleeding in acute coronary syndromes. Granger CB Timely Top Med Cardiovasc Dis; 2006 Nov; 10():E30. PubMed ID: 17136236 [No Abstract] [Full Text] [Related]
9. Thrombotic thrombocytopenic purpura and heparin-induced thrombocytopenia: two unique causes of life-threatening thrombocytopenia. Marques MB Clin Lab Med; 2009 Jun; 29(2):321-38. PubMed ID: 19665681 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial. White HD; Kleiman NS; Mahaffey KW; Lokhnygina Y; Pieper KS; Chiswell K; Cohen M; Harrington RA; Chew DP; Petersen JL; Berdan LG; Aylward PE; Nessel CC; Ferguson JJ; Califf RM Am Heart J; 2006 Dec; 152(6):1042-50. PubMed ID: 17161049 [TBL] [Abstract][Full Text] [Related]
16. Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study. Gettings EM; Brush KA; Van Cott EM; Hurford WE Crit Care; 2006; 10(6):R161. PubMed ID: 17109753 [TBL] [Abstract][Full Text] [Related]
17. Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: findings from the global registry of acute coronary events (GRACE). Montalescot G; Van de Werf F; Gulba DC; Avezum A; Brieger D; Kennelly BM; Mazurek T; Spencer F; White K; Gore JM; Catheter Cardiovasc Interv; 2003 Nov; 60(3):360-7. PubMed ID: 14571488 [TBL] [Abstract][Full Text] [Related]
18. Role of enoxaparin in the invasive management of the ACS patient. Hermiller JB J Invasive Cardiol; 2004 Feb; 16(2):52-3. PubMed ID: 14760189 [No Abstract] [Full Text] [Related]
19. Analysis of bleeding complications associated with glycoprotein IIb/IIIa receptors blockade in patients with high-risk acute coronary syndromes: insights from the PRISM-PLUS study. Huynh T; Piazza N; DiBattiste PM; Snapinn SM; Wan Y; Pharand C; Theroux P Int J Cardiol; 2005 Apr; 100(1):73-8. PubMed ID: 15820288 [TBL] [Abstract][Full Text] [Related]
20. A perspective on trials comparing enoxaparin and unfractionated heparin in the treatment of non-ST-elevation acute coronary syndromes. Califf RM; Petersen JL; Hasselblad V; Mahaffey KW; Ferguson JJ Am Heart J; 2005 Apr; 149(4 Suppl):S91-9. PubMed ID: 16124953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]